Home/Pipeline/Vaxine Opioid Addiction Vaccine

Vaxine Opioid Addiction Vaccine

Opioid Use Disorder

PreclinicalActive

Key Facts

Indication

Opioid Use Disorder

Phase

Preclinical

Status

Active

Company

AI‑enhanced vaccine developer using the Advax™ adjuvant platform for infectious disease and immunotherapy.

Drug	Company	Phase	Status
TRV734	Trevena	Phase 1	Active
FP-004 (SIF Formulation)	Foresee Pharmaceuticals	Preclinical	Active
Safer Ibogaine Analogs	Gilgamesh Pharmaceuticals	Pre-clinical/Research	Active (NIDA Grant Funded)
AM-510	Aion Medicines	Discovery	Active
Naltrexone Implant	Delpor	Phase 1	Active
Platform Expansion	Amygdala Neurosciences	Research	Active
Undisclosed OUD Program	Epiodyne	Pre-clinical	Active
AQL™-Naltrexone	Plumb Pharmaceuticals	Pre-clinical	Active
MEB-1170	Mebias Discovery	Phase 1	Active
SUBLOCADE®	Indivior PLC	Marketed	Commercial